India details ₹174 crore backing for nanomedicine research

A New Delhi congress examines targeted treatments, diagnostics and the challenge of turning laboratory work into medical products.

Asal Sach

27 September 2026 · 1 min read

Article

Report prepared 27 Sept 2026, 11:42 pm IST · Event date shown above

AI illustration

AI-generated editorial illustration of Indian health research, with a fictional researcher and symbolic molecular forms. Not a photograph of the reported participants, a clinical result or an anatomical diagram.

Understand this story

ASAL AI

Editorial summary

A New Delhi congress examines targeted treatments, diagnostics and the challenge of turning laboratory work into medical products.

Event / development: 27 Sept 2026
Location: National

Use neural AI on this report

Generate a short AI reading note. First use downloads about 290 MB; slower devices may not support it. Questions stay on your device.

India's biotechnology department is supporting 210 nanomedicine research projects with ₹174 crore, Science and Technology Minister Jitendra Singh said on September 27. He presented the funding picture at the opening of the World Congress on Nanomedicine in New Delhi, attended by more than 2,000 participants.

The projects span targeted drug delivery, cancer and infectious diseases, imaging, wound healing and safety research. Singh pointed to investigations involving oral insulin nanoparticles and breast cancer nanobots as examples of work seeking more precise ways to deliver treatment inside the body.

The discussion also covered the route from research to usable products. Biotechnology enterprises can seek support through BIRAC programmes, while joint guidelines from India's biotechnology, medical research and drug regulation bodies provide an evaluation framework. The minister also urged medical education to preserve clinical judgement as new technologies enter practice.